8 ASX 200 shares with fresh buy ratings this week

Brokers retained a positive view on Westpac, Sonic Healthcare, Minerals 260, and other shares.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

S&P/ASX 200 Index (ASX: XJO) shares are down 0.8% to 9,113.8 points as earnings season continues on Friday.

Brokers have indicated continued optimism for share price growth with several ASX 200 stocks this week.

Let's check them out.

Businessman studying a high technology holographic stock market chart.

Image source: Getty Images

Resmed CDI (ASX: RMD)

The Resmed share price is $32.11, up 1% today and down 27% over 12 months. 

Morgans renewed its buy rating on the ASX 200 healthcare share this week.

The broker trimmed its 12-month price target from $40.97 to $39.50.

This suggests a potential 23% upside ahead.

Resmed is among 8 ASX shares going ex-dividend next week.

Westpac Banking Corp (ASX: WBC)

The Westpac share price is $35.46, down 0.7% today and down 2% over 12 months. 

UBS reaffirmed its buy rating on the ASX 200 bank share with a 12-month target of $45.

This suggests a potential 27% upside ahead.

Minerals 260 Ltd (ASX: MI6)

The Minerals 260 share price is 74 cents, down 4.9% today and up 471% over 12 months. 

Nope, that's not a typo!

Minerals 260 is a gold mineral explorer building the Bullabulling Project in Western Australia.

In FY26, the miner was No. 2 among the 5 best-performing ASX 200 shares for capital growth.

UBS thinks this stock has more room to run.

The broker reiterated its buy rating on Minerals 260 shares with a price target of 90 cents.

This implies potential capital gains of 22% over FY27.

ANZ Group Holdings Ltd (ASX: ANZ

The ANZ share price is $38.73, up 1.8% today and up 19% over 12 months. 

ANZ reported an increase in its cash profit and net interest margin (NIM) for 3Q FY26 yesterday.

However, it noted a downturn in the value of mortgage loan applications since the Federal Budget.

Citi renewed its buy rating on ANZ shares with a $39.25 price target.

This suggests the ASX 200 bank stock is almost fully valued.

Sonic Healthcare Ltd (ASX: SHL)

The Sonic Healthcare share price is $22.19, down 1% today and down 22% over 12 months. 

Healthcare is on a comeback tour after plunging to a nine-year low in June.

Since the sector turned on 3 June, ASX 200 healthcare shares have ripped 30% as a group.

Value investors have swooped in, and Sonic Healthcare is benefitting from the attention.

The Sonic Healthcare share price has risen 18% since 3 June.

This week, Bell Potter renewed its buy rating on Sonic Healthcare shares with a $28.75 target.

This implies potential capital growth of 30% over the next year.

Insurance Australia Group Ltd (ASX: IAG)

The IAG share price is $8.06, up 3.1% today and down 6% over 12 months. 

UBS maintained its buy rating on IAG shares following the insurer's FY26 results yesterday.

The broker reduced its 12-month price target from $9.45 to $9.25.

This implies a potential 15% upside ahead for IAG shares.

Megaport Ltd (ASX: MP1)

The Megaport share price is $21.58, down 0.5% today and up 49% over 12 months. 

UBS renewed its buy rating on the ASX 200 tech share on Wednesday.

The broker has a 12-month price target of $24.20 on Megaport shares.

This suggests a potential 12% upside ahead.

Bank of Queensland Ltd (ASX: BOQ)

The Bank of Queensland share price is $6.42, up 0.2% today and down 17% over 12 months. 

Morgans reiterated its buy rating on the ASX 200 financial share with a price target of $6.94.

This implies a potential 8% upside ahead.

Citigroup is an advertising partner of Motley Fool Money. Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Megaport and ResMed. The Motley Fool Australia has positions in and has recommended ResMed. The Motley Fool Australia has recommended Sonic Healthcare. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Woman working on her laptop at a café.
Broker Notes

7 ASX 200 shares downgraded by the experts this week

Brokers reduced their ratings on IAG, Seek, Woolworths, and other ASX 200 stocks.

Read more »

Man drawing an upward line on a bar graph symbolising a rising share price.
Broker Notes

Morgans names 3 ASX shares to buy

The broker has good things to say about these shares. Here's what you need to know.

Read more »

A young woman holding her phone smiles broadly and looks excited, after receiving good news.
Broker Notes

The dividend yield on this ASX tech stock could more than double: Broker

It's had a bumpy ride this week, but this share could generate strong returns.

Read more »

Smiling woman with her head and arm on a desk holding $100 notes, symbolising dividends.
Broker Notes

For a yield of more than 7% and capital gains check out this ASX property trust: Broker

Could this company deliver the best of both worlds?

Read more »

An aircraft maintenance technician stands atop a platform inspecting the jets of an aircraft within a hangar.
Broker Notes

This ASX critical minerals producer could more than triple in value: Broker

This hi-tech company is growing its revenues fast.

Read more »

Stressed shopper holding shopping bags.
Broker Notes

Premier Investments shares will go how high? 2 brokers have their say

Are these shares looking like a bargain?

Read more »

Stressed man in an an office with his eyes closed and phone in his hand, with investing graphs open on two iMacs.
Broker Notes

Why Bell Potter just downgraded this popular ASX 200 stock

The broker is feeling cautious about this fallen giant.

Read more »

Image of a fist holding two yellow lightning bolts against a red backdrop.
Broker Notes

How high do brokers think AGL shares will go?

Is the power company looking undervalued?

Read more »